Small entrepreneurial firms and large companies in inter-firm R&D networks – the international biotechnology industry

J. Hagedoorn, A.H.W.M. Roijakkers

Research output: Chapter in Book/Report/Conference proceedingChapterAcademicpeer-review

Abstract

This chapter studies the role played by small entrepreneurial firms and large companies in the international biotechnology industry. The biotechnology industry is one of the main examples of current industries that are characterized by "hypercompetition" (D'Aveni, 1994), with a high degree of uncertainty about the combined effects of both new technologies and new market structures. It is an example of an industry with Schumpeterian competition where revolutionary changes in technology and innovative new products and processes have the potential to threaten the position of existing market leaders and their product-market positions (Liebeskind et al., 1996). It is also a sector where we find a large number of R&D alliances, in particular between large and small companies (Hagedoorn, 1996a; Kenney, 1986; Powell, 1996).Throughout this chapter we will refer to the biotechnology "industry" although, given the above-mentioned characteristics, this is probably an incorrect term as its status as a separate industrial sector is still somewhat unclear. Strictly taken, biotechnology is not yet a regular industrial sector but a hybrid form of an "industry" with established companies, e.g., from the pharmaceutical sector, and a wide range of new biotechnology companies that are science based and technology driven but still with relatively few regular products and limited manufacturing capabilities ... log in or subscribe to read full text
Original languageEnglish
Title of host publicationStrategic entrepreneurship: creating a new integrated mindset
EditorsM. Hitt, D. Ireland, M. Camp, D. Sexton
Place of PublicationLondon
PublisherWiley-Blackwell
Pages223-252
DOIs
Publication statusPublished - 2002

Fingerprint

Entrepreneurial firms
Biotechnology industry
Large companies
Industry
Biotechnology
Industrial sector
Product market
Market position
Uncertainty
Small companies
Hypercompetition
New markets
Pharmaceuticals
Alliances
Schumpeterian competition
Market structure
Manufacturing
New products

Cite this

Hagedoorn, J., & Roijakkers, A. H. W. M. (2002). Small entrepreneurial firms and large companies in inter-firm R&D networks – the international biotechnology industry. In M. Hitt, D. Ireland, M. Camp, & D. Sexton (Eds.), Strategic entrepreneurship: creating a new integrated mindset (pp. 223-252). London: Wiley-Blackwell. https://doi.org/10.1111/b.9780631234104.2002.00011.x
Hagedoorn, J. ; Roijakkers, A.H.W.M. / Small entrepreneurial firms and large companies in inter-firm R&D networks – the international biotechnology industry. Strategic entrepreneurship: creating a new integrated mindset. editor / M. Hitt ; D. Ireland ; M. Camp ; D. Sexton. London : Wiley-Blackwell, 2002. pp. 223-252
@inbook{a3d248cb85924b5597c0ce2d8696bc9c,
title = "Small entrepreneurial firms and large companies in inter-firm R&D networks – the international biotechnology industry",
abstract = "This chapter studies the role played by small entrepreneurial firms and large companies in the international biotechnology industry. The biotechnology industry is one of the main examples of current industries that are characterized by {"}hypercompetition{"} (D'Aveni, 1994), with a high degree of uncertainty about the combined effects of both new technologies and new market structures. It is an example of an industry with Schumpeterian competition where revolutionary changes in technology and innovative new products and processes have the potential to threaten the position of existing market leaders and their product-market positions (Liebeskind et al., 1996). It is also a sector where we find a large number of R&D alliances, in particular between large and small companies (Hagedoorn, 1996a; Kenney, 1986; Powell, 1996).Throughout this chapter we will refer to the biotechnology {"}industry{"} although, given the above-mentioned characteristics, this is probably an incorrect term as its status as a separate industrial sector is still somewhat unclear. Strictly taken, biotechnology is not yet a regular industrial sector but a hybrid form of an {"}industry{"} with established companies, e.g., from the pharmaceutical sector, and a wide range of new biotechnology companies that are science based and technology driven but still with relatively few regular products and limited manufacturing capabilities ... log in or subscribe to read full text",
author = "J. Hagedoorn and A.H.W.M. Roijakkers",
year = "2002",
doi = "10.1111/b.9780631234104.2002.00011.x",
language = "English",
pages = "223--252",
editor = "M. Hitt and D. Ireland and M. Camp and D. Sexton",
booktitle = "Strategic entrepreneurship: creating a new integrated mindset",
publisher = "Wiley-Blackwell",
address = "United States",

}

Hagedoorn, J & Roijakkers, AHWM 2002, Small entrepreneurial firms and large companies in inter-firm R&D networks – the international biotechnology industry. in M Hitt, D Ireland, M Camp & D Sexton (eds), Strategic entrepreneurship: creating a new integrated mindset. Wiley-Blackwell, London, pp. 223-252. https://doi.org/10.1111/b.9780631234104.2002.00011.x

Small entrepreneurial firms and large companies in inter-firm R&D networks – the international biotechnology industry. / Hagedoorn, J.; Roijakkers, A.H.W.M.

Strategic entrepreneurship: creating a new integrated mindset. ed. / M. Hitt; D. Ireland; M. Camp; D. Sexton. London : Wiley-Blackwell, 2002. p. 223-252.

Research output: Chapter in Book/Report/Conference proceedingChapterAcademicpeer-review

TY - CHAP

T1 - Small entrepreneurial firms and large companies in inter-firm R&D networks – the international biotechnology industry

AU - Hagedoorn, J.

AU - Roijakkers, A.H.W.M.

PY - 2002

Y1 - 2002

N2 - This chapter studies the role played by small entrepreneurial firms and large companies in the international biotechnology industry. The biotechnology industry is one of the main examples of current industries that are characterized by "hypercompetition" (D'Aveni, 1994), with a high degree of uncertainty about the combined effects of both new technologies and new market structures. It is an example of an industry with Schumpeterian competition where revolutionary changes in technology and innovative new products and processes have the potential to threaten the position of existing market leaders and their product-market positions (Liebeskind et al., 1996). It is also a sector where we find a large number of R&D alliances, in particular between large and small companies (Hagedoorn, 1996a; Kenney, 1986; Powell, 1996).Throughout this chapter we will refer to the biotechnology "industry" although, given the above-mentioned characteristics, this is probably an incorrect term as its status as a separate industrial sector is still somewhat unclear. Strictly taken, biotechnology is not yet a regular industrial sector but a hybrid form of an "industry" with established companies, e.g., from the pharmaceutical sector, and a wide range of new biotechnology companies that are science based and technology driven but still with relatively few regular products and limited manufacturing capabilities ... log in or subscribe to read full text

AB - This chapter studies the role played by small entrepreneurial firms and large companies in the international biotechnology industry. The biotechnology industry is one of the main examples of current industries that are characterized by "hypercompetition" (D'Aveni, 1994), with a high degree of uncertainty about the combined effects of both new technologies and new market structures. It is an example of an industry with Schumpeterian competition where revolutionary changes in technology and innovative new products and processes have the potential to threaten the position of existing market leaders and their product-market positions (Liebeskind et al., 1996). It is also a sector where we find a large number of R&D alliances, in particular between large and small companies (Hagedoorn, 1996a; Kenney, 1986; Powell, 1996).Throughout this chapter we will refer to the biotechnology "industry" although, given the above-mentioned characteristics, this is probably an incorrect term as its status as a separate industrial sector is still somewhat unclear. Strictly taken, biotechnology is not yet a regular industrial sector but a hybrid form of an "industry" with established companies, e.g., from the pharmaceutical sector, and a wide range of new biotechnology companies that are science based and technology driven but still with relatively few regular products and limited manufacturing capabilities ... log in or subscribe to read full text

U2 - 10.1111/b.9780631234104.2002.00011.x

DO - 10.1111/b.9780631234104.2002.00011.x

M3 - Chapter

SP - 223

EP - 252

BT - Strategic entrepreneurship: creating a new integrated mindset

A2 - Hitt, M.

A2 - Ireland, D.

A2 - Camp, M.

A2 - Sexton, D.

PB - Wiley-Blackwell

CY - London

ER -

Hagedoorn J, Roijakkers AHWM. Small entrepreneurial firms and large companies in inter-firm R&D networks – the international biotechnology industry. In Hitt M, Ireland D, Camp M, Sexton D, editors, Strategic entrepreneurship: creating a new integrated mindset. London: Wiley-Blackwell. 2002. p. 223-252 https://doi.org/10.1111/b.9780631234104.2002.00011.x